Latest chemotherapy Stories

2014-07-23 23:08:15

A curcumin analog and a drug normally used to prevent rejection of organ transplants may make mesothelioma cells more susceptible to chemotherapy. Raleigh, NC (PRWEB) July 23, 2014 Researchers in Turkey say a compound called EF24, which is chemically similar to the yellow pigment in the spice turmeric, and an immunosuppressor called RAD001 helped scientists destroy mesothelioma cells in the lab. To read the full story on Surviving Mesothelioma, click here now. Scientists at Gazi...

2014-07-17 23:10:07

The Mesothelioma Compensation Center is urging a diagnosed victim of mesothelioma, or their family members to call them at 866-714-6466 for instant access to the nation's most skilled mesothelioma compensation attorneys, along with personalized research for possible treatment options including chemotherapy. However, as the Compensation Center would like to explain, treatments options such as chemotherapy must occur simultaneously with mesothelioma legal experts who are focused on...

2014-07-11 23:09:19

Capital Institute for Neurosciences Begins Clinical Trial Delivering Chemotherapy Directly to Brain Tumors Starting with Incision in Leg Hopewell, NJ (PRWEB) July 11, 2014 The Capital Institute for Neurosciences at Capital Health today announced it has performed the first procedure in a clinical trial that delivers chemotherapy to brain tumors through a catheter inserted in the leg. During the procedure, done at Capital Health Medical Center – Hopewell, Dr. Erol Veznedaroglu, an...

2014-07-11 23:05:26

Scientists say slight inherited differences in the genes may help predict how mesothelioma patients will respond to chemotherapy. Raleigh, NC (PRWEB) July 11, 2014 Cancer researchers in Slovenia say genetic variations called polymorphisms appear to have a significant impact on how patients respond to treatment with pemetrexed (Alimta), the most popular chemotherapy drug for mesothelioma. Surviving Mesothelioma has the full story. Click here to read the new post now. Researchers at the...

2014-07-10 23:12:03

MedActive Oral Pharmaceuticals to Sponsor American Cancer Society's 'Fight Cancer from the Fairways' Golf Tournament Odessa, FL (PRWEB) July 10, 2014 MedActive Oral Pharmaceuticals, LLC is proud to announce its sponsorship of the upcoming 'Fight Cancer from the Fairways' golf tournament, staged by the American Cancer Society at Caves Valley Golf Club in Owings Mills, Maryland on September 22, 2014. MedActive recently committed to join with the American Cancer Society...

2014-07-10 08:27:19

SEOUL, South Korea, BUSAN, South Korea and SAN FRANCISCO, July 10, 2014 /PRNewswire/ -- SillaJen, Inc., a privately-held biotherapeutics company focused on the development of targeted oncolytic immunotherapy products for cancer, announced today a publication that reviews data from the company's oncolytic immunotherapy program, including its lead product Pexa-Vec. Additionally, the publication outlines the rationale for combination therapy with other cancer immunotherapies, such as...

2014-07-10 08:27:07

LUGANO, Switzerland, July 10, 2014 /PRNewswire/ -- Helsinn Group, the company focused on building quality cancer care, today announces that the complete results of the three Phase 2/3 pivotal trials for the investigational oral fixed-dose combination capsule of netupitant 300 mg + oral palonosetron 0.50 mg (NEPA), which is licensed to Eisai Inc. in the United States, have been published, together with an accompanying editorial, in the July issue of Annals of Oncology....

2014-07-09 08:27:52

VANCOUVER, British Columbia and MENLO PARK, Calif., July 9, 2014 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") announced today that the company has been awarded a non-refundable financial contribution of up to CDN$194,000 from the National Research Council of Canada's Industrial Research Assistance Program (NRC-IRAP). The research funded by this award will be conducted in collaboration with the University of British Columbia, the Vancouver Prostate Centre and...

2014-07-08 23:09:40

Top mesothelioma researchers say an immunotoxin may have the power to significantly improve the effectiveness of chemotherapy in patients with malignant pleura mesothelioma. Raleigh, NC (PRWEB) July 08, 2014 According to a new NIH research study, more than three quarters of mesothelioma patients responded to chemotherapy when they were also given the anti-mesothelin immunotoxin SS1P. Click here to read Surviving Mesothelioma’s newly-posted article on how this important study may impact...

2014-07-08 23:07:23

Dalton Pharma Services signs agreement with GLyPharma Therapeutics Inc., to provide aseptic fill/finish services and analytical services for FE 203799 for cancer patients. Toronto, Ontario (PRWEB) July 08, 2014 Dalton Pharma Services, a privately owned Canadian pharmaceutical services provider to leading pharmaceutical companies, today announced the company has entered into a Manufacturing Services Agreement with GLyPharma Therapeutics Inc., a specialty pharma company based in Montreal,...

Latest chemotherapy Reference Libraries

Intravenous Therapy
2013-04-30 13:16:16

Intravenous therapy, commonly known as IV therapy, is known as the administration of a liquid substance directly into a vein. It is also known as drip therapy, because most often the liquid is suspended above the IV site by an infusion pump, and runs through a drip chamber, which prevents air from entering the line. IVs are the preferred method of drug administration in hospital settings because they are the fastest known route of getting medication to the body. Intravenous therapy can also...

Antiviral Chemistry & Chemotherapy
2012-04-25 09:59:26

Antiviral Chemistry & Chemotherapy is a peer-reviewed academic journal published bi-monthly by International Medical Press in London since 1997. When founded in January 1990, it was published by Blackwell Science. The current editor-in-chief is Hugh J. Field of University of Cambridge, UK. The journal publishes primary papers and reviews on all aspects of the preclinical development of antiviral agents, including their chemical synthesis, biochemistry, pharmacology, mode of action and...

More Articles (2 articles) »
Word of the Day
  • A murmuring sound; a rushing or whistling sound, like that of the wind; a deep sigh.
  • A gentle breeze; a waft; a breath.
  • Any rumor that engages general attention.
  • A cant or whining mode of speaking, especially in preaching or praying; the chant or recitative characteristic of the old Presbyterians in Scotland.
  • To make a rushing, whistling, or sighing sound; emit a hollow murmur; murmur or sigh like the wind.
  • To breathe in or as in sleep.
  • To utter in a whining or monotonous tone.
According to the OED, from the 16th century, this word is 'almost exclusively Scots and northern dialect until adopted in general literary use in the 19th.'